← All organizations
Meridien Research
For profitWebsite ↗
Also known as: MERIDIAN BIOSCIENCE | Meridian Bioscience, Inc. | Meridian Clinical Research | Meridian Clinical Research, Bellevue, NE 68005 | Meridian Clinical Research, Omaha (NE), USA | Meridian Clinical Research, Savannah (GA), USA | Meridien Research, Brooksville, FL 34601 | Meridien Research Inc. | Meridien Research - Tampa
Highest phase reached
Phase 3
Timeline
2000s
- Jan 1, 2000
Meridien Research— Founded
- Dec 17, 2002
urea-13c— NDA Secondary Org
2010s
- Oct 1, 2016
Florida Clinical Research Center, LLC— Acquired
Drugs by trial phase (25 distinct, 23 trials)
Phase 4 (0 own, 3 via acquisition)
Phase 3 (9 own, 1 via acquisition)
Phase 2 (7 own, 3 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Atrophic Vaginitis
- Atrophy
- Attention Deficit Disorder with Hyperactivity
- Communicable Diseases
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Headache
- Hot Flashes
- Hyperkinesis
- Hypertriglyceridemia
- Infections
- Influenza, Human
- Migraine Disorders
- Osteoarthritis
- Respiratory Tract Diseases
- Respiratory Tract Infections
- RNA Virus Infections
- Vaginitis
- Virus Diseases
Marketed drugs (2)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (18)
- NCT04439695Overall official - principal investigatorPhase 1Jun 23, 2020
- NCT03834766Overall official - principal investigatorPhase 3Feb 6, 2019
- NCT03611101Lead sponsorN/AMay 4, 2018
- NCT03462576Lead sponsorN/AJun 28, 2017
- NCT03439189Lead sponsorN/AAug 28, 2016
- NCT02831751Overall official - principal investigatorPhase 2Apr 1, 2016
- NCT02195986Overall official - principal investigatorPhase 3Jun 1, 2014
- NCT01819272Overall official - principal investigatorPhase 2Apr 1, 2013
- NCT01825200Overall official - principal investigatorPhase 3Mar 1, 2013
- NCT01787188Overall official - principal investigatorPhase 3Feb 1, 2013
- NCT01728753Overall official - principal investigatorPhase 1/Phase 2Nov 1, 2012
- NCT01510912Overall official - principal investigatorPhase 3Jan 1, 2012
- NCT01461369Overall official - principal investigatorPhase 3Oct 1, 2011
- NCT01211782Overall official - principal investigatorPhase 2/Phase 3Sep 24, 2010
- NCT01101841Overall official - principal investigatorPhase 3Mar 1, 2010
Details
- Founded
- Tampa, FL, US Jan 1, 2000
- Last known activity
- Jun 23, 2020
Notes
CRO